Cargando…
Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries
Prostacyclin analogues are standard therapeutic options for vasoconstrictive diseases, including pulmonary hypertension and Raynaud’s phenomenon. Although effective, these treatment strategies are expensive and have several side effects. To improve drug efficiency, we tested liposomal nanoparticles...
Autores principales: | Jain, Pritesh P, Leber, Regina, Nagaraj, Chandran, Leitinger, Gerd, Lehofer, Bernhard, Olschewski, Horst, Olschewski, Andrea, Prassl, Ruth, Marsh, Leigh M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094575/ https://www.ncbi.nlm.nih.gov/pubmed/25045260 http://dx.doi.org/10.2147/IJN.S63190 |
Ejemplares similares
-
Peptides at the Interface: Self-Assembly of Amphiphilic
Designer Peptides and Their Membrane Interaction Propensity
por: Kornmueller, Karin, et al.
Publicado: (2016) -
Rho-Kinase Inhibition Ameliorates Dasatinib-Induced Endothelial Dysfunction and Pulmonary Hypertension
por: Fazakas, Csilla, et al.
Publicado: (2018) -
Revisiting the Large-Conductance Calcium-Activated Potassium (BKCa) Channels in the Pulmonary Circulation
por: Guntur, Divya, et al.
Publicado: (2021) -
TMEM16A Potentiation: Possible Drawbacks
por: Olschewski, Andrea, et al.
Publicado: (2020) -
The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension
por: Gessler, Tobias, et al.
Publicado: (2017)